Maria F. M.
- Country
- Poland
- Department
- N/A
Research Overview
Data & Insights
Has run more than one trial at 0 of 111 partner sites.
Specializations
Allergic Respiratory Disorders
Focuses on the treatment of seasonal and perennial Allergic rhinitis, Allergic rhinoconjunctivitis, and Asthma, including associated Chronic rhinosinusitis.
- Allergen immunotherapy
- Biologic agents for eosinophilic inflammation
- Management of pollen‑induced symptoms
- Therapies for chronic sinus disease
Therapeutic development aims at reducing symptom burden and exacerbations.
Dermatology and Immune‑Mediated Skin Conditions
Investigates innovative therapies for chronic inflammatory skin disorders such as Atopic dermatitis, Psoriasis, Chronic spontaneous urticaria, Hidradenitis suppurativa and Prurigo nodularis.
- IL‑4/IL‑13 pathway inhibition
- JAK‑inhibitor strategies
- Targeted biologics for severe eczema
- Novel topical formulations for urticaria
Emphasis on long‑term safety and quality‑of‑life outcomes.
Gastrointestinal Inflammatory Diseases
Dedicated to advancing care for inflammatory bowel conditions including Crohn's disease, Ulcerative colitis and broader Inflammatory bowel disease.
- Selective sphingosine‑1‑phosphate receptor modulators
- Anti‑integrin therapies
- Maintenance strategies for mucosal healing
- Combination regimens with immunosuppressants
Goal is sustained remission with minimized systemic exposure.
Metabolic and Cardiovascular Medicine
Engages in trials addressing metabolic syndrome and cardiovascular risk, covering Type 2 diabetes, Obesity, Hypertension, Atrial fibrillation, Heart failure and Atherosclerotic cardiovascular disease.
- GLP‑1 receptor agonist effects on retinal outcomes
- Weight‑loss interventions for low back pain
- Anticoagulant alternatives for stroke prevention
- Lipid‑lowering agents in high‑risk populations
Focus on integrated management of cardiometabolic comorbidities.
Ophthalmology and Vision‑Related Disorders
Targets ocular diseases with systemic and local therapeutic approaches, including Diabetic macular edema, Neovascular age‑related macular degeneration and Thyroid eye disease.
- Intravitreal combination therapies
- Anti‑VEGF biosimilar evaluation
- Immunomodulation for orbital inflammation
- Long‑term visual acuity preservation
Therapeutic aim is to prevent vision loss and improve functional outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.